Regulus Therapeutics (RGLS) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

RGLS Regulus Therapeutics

Watchlist

1.4900
0.00000.00%

Close Nov 4 16:00 ET

1.4898
-0.0002-0.01%

Post 16:32 ET

97.54MMarket Cap-1241P/E (TTM)

Post-Market

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Express News | Watching Regulus Therapeutics; Shares See Volume To The Upside As Traders Circulate TipRanks Article Titled 'These 2 'Strong Buy' Penny Stocks Could Rally Over 500%, Say Analysts'
BenzingaOct 28 11:22 ET
Regulus Therapeutics Completes Enrollment in Phase 1b Kidney Disease Drug Trial
MT NewswiresOct 8 11:32 ET
H.C. Wainwright Maintains Regulus Therapeutics(RGLS.US) With Buy Rating, Maintains Target Price $10
Moomoo NewsOct 8 10:31 ET · Ratings
Express News | Regulus Therapeutics Inc: Remain on Track for an End of Phase 1 Meeting With FDA by End of 2024
ReutersOct 8 08:01 ET
Express News | Regulus Therapeutics Announces Completion of Enrollment in Fourth Cohort of Phase 1B Multiple-Ascending Dose (Mad) Clinical Trial of Rgls8429 for the Treatment of Patients With Autosomal Dominant Polycystic Kidney Disease (Adpkd)
ReutersOct 8 08:00 ET
Regulus Therapeutics Announces Completion of Enrollment in Fourth Cohort of Phase 1b Multiple-Ascending Dose (MAD) Clinical Trial of RGLS8429 for the Treatment of Patients With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Yahoo FinanceOct 8 08:00 ET

Comments

Stock_Drift

Oct 24 15:16

After Hours Ticks. 4:15pm

$Visionary Holdings (GV.US)$ $Western Digital (WDC.US)$ $Integrated Media Technology (IMTE.US)$ $Deckers Outdoor (DECK.US)$ $MediaCo (MDIA.US)$ $Skechers USA (SKX.US)$ $Regulus Therapeutics (RGLS.US)$ $Abits (ABTS.US)$ $Spark I Acquisition Corporation (SPKL.US)$ $Tapestry (TPR.US)$ $Antelope Enterprise (AEHL.US)$ $Jeffs' Brands (JFBR.US)$ $Lyell Immunopharma (LYEL.US)$ $Smart Powerr (CREG.US)$ $Bionomics (BNOX.US)$
📊⚡️📊

Trytosaveabit

Oct 8 07:03

Update

$Regulus Therapeutics (RGLS.US)$ Regulus Therapeutics Inc: Remain on Track for an End of Phase 1 Meeting With FDA by End of 2024

Jaguar8

Oct 8 07:02

NEWS

$Regulus Therapeutics (RGLS.US)$
Regulus Therapeutics Announces Completion of Enrollment in Fourth Cohort of Phase 1b Multiple-Ascending Dose (MAD) Clinical Trial of RGLS8429 for the Treatment of Patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD)